DarioHealth extends preferred stock lock-up to Feb 2026; amends certificates for warrant dividends

DarioHealth Corp.

Amended lock-up agreements with Series B/C preferred holders extend restrictive period until February 21, 2026.
Holders receive additional 10% of common stock underlying preferred shares for each 3-month extension.
Company filed amended certificates for Series A-1 and B-1 preferred stock to allow dividends in pre-funded warrants.
No new securities issued under certificate amendments; provides alternative form for future dividends.
Breach of lock-up before Eligibility Date forfeits right to subsequent share consideration.

item 1.01 item 3.02 item 3.03 item 5.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

DarioHealth Corp.: Amended Series A-1 and Series B-1 Certificates of Designation to allow dividends/distributions in the form of pre-funded common stock purchase warrants instead of common stock (effective 2025-05-20).

Change: charter amendment
Effective: 2025-05-20

Exact text from the filing

On May 20, 2025, the Company, upon obtaining the vote of a majority of the holders of the relevant classes of preferred stock, filed an Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of the Company’s Series A-1 Preferred Stock (the “Series A-1 Certificate of Designation”) and a Third Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of the Company’s Series B-1 Preferred Stock

View on SEC.gov

13 governance changes filed in the last 30 days. Browse all governance changes →

DarioHealth Corp. filing history →

Source: SEC EDGAR

accession 0001104659-25-054236

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.